{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:44:56Z","timestamp":1747309496986},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)"},{"name":"Capital Foundation of Medical Developments (CFMD)"},{"name":"Pumch Science Fund for Junior Faculty"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.leukres.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T17:47:48Z","timestamp":1527184068000},"page":"56-61","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"70","author":[{"given":"Mengxuan","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haorui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.leukres.2018.05.008_bib0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann. Oncol."},{"issue":"25","key":"10.1016\/j.leukres.2018.05.008_bib0010","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2018.05.008_bib0015","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/10428190802455867","article-title":"Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States","volume":"49","author":"Abouyabis","year":"2008","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.leukres.2018.05.008_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) Fo xP3(+)T cells","volume":"21","author":"X.Z","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.leukres.2018.05.008_bib0025","first-page":"737","article-title":"Detection of peripheral blood CD4+ CD25high CD127low regulatory T cells in patients with B-cell non-Hodgkin lymphoma and its clinical significance","volume":"23","author":"Bai","year":"2014","journal-title":"J. Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.leukres.2018.05.008_bib0030","first-page":"462","article-title":"Correlation of the expression and prognosis of FOXP3\u202f+\u202fTreg and IL-10 in diffuse large B-cell lymphoma","volume":"46","author":"Wu","year":"2011","journal-title":"ACTA Univ. Medicinalis Anhu"},{"issue":"11","key":"10.1016\/j.leukres.2018.05.008_bib0035","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/sj.emboj.7601146","article-title":"T-cell tolerance or function is determined by combinatorial costimulatory signals","volume":"25","author":"Nurieva","year":"2006","journal-title":"EMBO J."},{"issue":"Suppl. 3","key":"10.1016\/j.leukres.2018.05.008_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/neuonc\/nou237.32","article-title":"Prospects for targeting PD-1 and PD-L1 in various tumor types","volume":"28","author":"Kim","year":"2014","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"3","key":"10.1016\/j.leukres.2018.05.008_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00428-014-1615-5","article-title":"Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma","volume":"465","author":"Ahearne","year":"2014","journal-title":"Virchows Arch."},{"issue":"21","key":"10.1016\/j.leukres.2018.05.008_bib0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood.V124.21.291.291","article-title":"Preliminary results of a phase I study of Nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies","volume":"124","author":"Lesokhin","year":"2014","journal-title":"Blood"},{"issue":"November (33)","key":"10.1016\/j.leukres.2018.05.008_bib0055","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2012.48.3685","article-title":"Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial","volume":"31","author":"Armand","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"May (10)","key":"10.1016\/j.leukres.2018.05.008_bib0060","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1078-0432.CCR-07-4079","article-title":"Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies","volume":"14","author":"Berger","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2018.05.008_bib0065","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"439","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2018.05.008_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/asheducation-2013.1.394","article-title":"Novel therapy for Hodgkin lymphoma","volume":"2013","author":"Batlevi","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Prog."},{"key":"10.1016\/j.leukres.2018.05.008_bib0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/asheducation-2013.1.553","article-title":"Targeting B-cell receptor signaling: changing the paradigm","volume":"2013","author":"Fowler","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Prog."},{"issue":"12","key":"10.1016\/j.leukres.2018.05.008_bib0080","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98. 5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2018.05.008_bib0085","first-page":"916","article-title":"PD-1 expression on the surface of peripheral blood CD4(+)T cell and its association with the prognosis of patients with peripheral T\/NK cell lymphoma","volume":"37","author":"Bai","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"May (5)","key":"10.1016\/j.leukres.2018.05.008_bib0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.1213633","article-title":"Th17 cells and Tregs: unlikely allies","volume":"95","author":"Chen","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.leukres.2018.05.008_bib0095","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/jcp.25016","article-title":"Treg(s) in cancer: friends or foe?","volume":"230","author":"Wolf","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.leukres.2018.05.008_bib0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cyto.b.21330","article-title":"Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients","volume":"90","author":"Gunduz","year":"2016","journal-title":"Cytometry Part B Clin. Cytometry"},{"issue":"13","key":"10.1016\/j.leukres.2018.05.008_bib0105","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-11-4094","article-title":"Cellular constituents of immune escape within the tumor microenvironment","volume":"72","author":"Kerkar","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.leukres.2018.05.008_bib0110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"7077","key":"10.1016\/j.leukres.2018.05.008_bib0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:02:33Z","timestamp":1620993753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618301103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":23,"alternative-id":["S0145212618301103"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}